12:00 AM
 | 
Sep 03, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Daiichi Sankyo, Mitsubishi Tanabe Pharma sales and marketing update

Mitsubishi and partner Daiichi Sankyo plan to launch Mitsubishi's Type II diabetes drug Tenelia teneligliptin ( MP-513) in Japan on...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >